In Vivo Gene Therapy: It’s All about Border Crossing
Priti Kumar, PhD
Yale School of Medicine
Kumar’s lab conducts translational research with a main focus on the development of novel gene therapies for viral infections. Over the last 7 years as faculty at Yale, Kumar’s lab has been involved in understanding the pathogenesis of RNA viruses like HIV and West Nile virus in relevant small animal models and expanding research efforts for prevention and treatment of infections caused by these viruses. Notable advances from the group have been the development and testing of novel gene therapeutic strategies for HIV in humanized mice, with the goal of enabling in vivo gene therapy in humans.
Center for Cell Circuitry